UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934
Check the appropriate box:
[ ] | Preliminary Proxy Statement |
[ ] | Confidential, for use of the Commission only as permitted by Rule 14a-6(e)(2) |
[ ] | Definitive Proxy Statement |
[X] | Definitive Additional Material |
[ ] | Solicitation Material under §240.14a-12 |
ProtoKinetix, Incorporated
(Name of Registrant as Specified in Its Charter)
Payment of filing fee (Check the appropriate box):
[X] | No fee required. |
[ ] | Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. |
1) | Title of each class of securities to which transaction applies: | |
2) | Aggregate number of securities to which transaction applies: | |
3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined): | |
4) | Proposed maximum aggregate value of transaction: | |
5) | Total fee paid: |
[ ] | Fee paid with preliminary materials. |
[ ] | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, of the Form or Schedule and the date of its filing. |
1) | Amount Previously Paid: | |
2) | Form, Schedule or Registration Statement No.: | |
3) | Filing Party: | |
4) | Date Filed: |
|
ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only
Marietta, Ohio, January 14, 2022- ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that it will hold its Annual General Meeting of the Stockholders of the Company (“AGM”) virtually with no option to attend the AGM in person due to ongoing COVID-19 concerns.
As set forth in the Company’s definitive proxy materials as filed with the Securities and Exchange Commission on December 30, 2021, the AGM will be held on Friday, February 11, 2022 at 4:00 p.m. Eastern Standard Time, via webcast at: www.virtualshareholdermeeting.com/PKTX2022.
If you have not received your proxy package, please contact the Company directly:
Clarence E. Smith
President and Chief Executive Officer
Telephone: 740-434-5041
Email: csmith@protokinetix.com
Twitter: @ProtoKinetix
About ProtoKinetix, Incorporated
This press release does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States.